abstract |
The present invention provides a novel anti-CTLA-4 antibody composition containing a chelating agent. Also provided are treatments for diseases and symptoms (including various neoplastic diseases) using the novel anti-CTLA-4 antibody compositions. An anti-CTLA-4 antibody composition according to the present invention comprises: a) at least one chelating agent; b) an amino acid sequence at least 90% identical to the heavy chain amino acid sequence shown in SEQ ID NO: 2; Comprising at least one antibody comprising an amino acid sequence that is at least 90% identical to the light chain amino acid sequence shown in SEQ ID NO: 4, wherein the antibody binds to human CTLA-4. [Selection figure] None |